Speaker illustration

Professor Naveed Sattar

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)

Member of:

European Society of Cardiology

Naveed Sattar is internationally recognised in cardiometabolic disease. He has epidemiology, mechanistic and trial expertise in diabetes, obesity and cardiovascular disease and contributed to several other randomised lifestyle trials. He has contributed to several trials of pharmaceutical agents in diabetes and to 8 national/international guidelines with relevance to diabetes, obesity and CV disease. He has co-authored over 1300 published papers and been cited >135K times (Web of Science) and >220K (Google Scholar), and appeared in the top 1% of cited clinical academics in the world annually since 2014 (Highly Cited Researcher). He was recipient of the Banting Lecture by Diabetes UK in 2023 and is a previous recipient of the Camillo Golgi and Minkowski Award Lectures by EASD. He is an Associate Editor for Diabetes Care. In late 2023 he was appointed as the UK Government’s new Obesity Mission Chair.

Immunity and cardiovascular risk

Event: ESC Preventive Cardiology 2024

Topic: Autoimmune/Chronic Inflammatory Disorders and Heart Disease

Session type: Symposium


Obesity care in people with cardiovascular disease: a neglected front? (Accredited by EACCME)

Event: ESC Congress 2019

Topic: Risk Factors and Prevention

Session type: Satellite Symposium


How do SGLT2 inhibitors and incretin-based therapy exert their effects on cardiovascular disease?

Event: ESC Congress 2018

Topic: Metabolic Syndrome, Insulin, Insulin Resistance

Session type: Symposium


Biomarker targeted approach in preventing heart failure among patients with diabetes

Event: Heart Failure 2018

Topic: Prevention

Session type: Satellite Symposium


Role of biomarkers to prevent heart failure development in diabetes patients

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Natriuretic peptides

Session type: Satellite Symposium - Experts on the Spot


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb